Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
6 p, 657.1 KB Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation : A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study / Paviglianiti, Annalisa (Centre Scientifique de Monaco) ; Tozatto Maio, Karina (Centre Scientifique de Monaco) ; Rocha, Vanderson (Hospital Sao Paulo) ; Gehlkopf, Eve (CHU Lapeyronie) ; Milpied, Noel (CHU Bordeaux) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Chevallier, Patrice (Hospital Hotel Dieu (Nantes, França)) ; Blaise, Didier (Institute Paoli Calmettes) ; Gac, Anne-Claire (Institut d'Hématologie de Basse-Normandie) ; Leblond, Véronique (Hopital la Pitié-Salpêtrière) ; Cahn, Jean-Yves (CHU Grenoble Alpes) ; Abecasis, Manuel (Institute Portugues Oncologia) ; Zuckerman, Tsila (Rambam Medical Center) ; Schouten, Harry (University Hospital Maastricht) ; Gurman, Gunhan (Ankara University) ; Rubio, Marie Thérèse (Hôpitaux des Brabois) ; Beguin, Yves (CHU of Liège and University of Liege) ; Corral, Lucia Lopez (Centro de Investigacion del Cancer-IBMCC) ; Nagler, Amon (Chaim Sheba Medical Center (Israel)) ; Snowden, John A. (Sheffield Teaching Hospitals NHS Trust) ; Koc, Yener (Stem Cell Transplant Unit Medical Park Hospitals) ; Mordini, Nicola (Az. Ospedaliera S. Croce e Carle) ; Bonifazi, Francesca ("Seragnoli" University Hospital S. Orsola-Malpighi) ; Volt, Fernanda (Centre Scientifique de Monaco) ; Kenzey, Chantal (Centre Scientifique de Monaco) ; Robinson, Stephen Paul (EBMT Lymphoma Working Party) ; Montoto, Silvia (EBMT Lymphoma Working Party) ; Gluckman, Eliane (Centre Scientifique de Monaco) ; Ruggeri, Annalisa (Bambin Gesù) ; Universitat Autònoma de Barcelona
Allogeneic stem cell transplantation is an alternative for patients with relapsed or refractory Hodgkin lymphoma (HL), but only limited data on unrelated umbilical cord blood transplantation (UCBT) are available. [...]
2018 - 10.1016/j.bbmt.2018.07.019
Biology of blood and marrow transplantation, Vol. 24 Núm. 11 (november 2018) , p. 2265-2270  
2.
10 p, 856.3 KB Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor / Sureda, Anna (Institut Català d'Oncologia) ; Chabannon, Christian (Institut Paoli-Calmettes) ; Masszi, Tamás (Semmelweis University) ; Pohlreich, David (Charles University Hospital) ; Scheid, Christof (University of Cologne) ; Thieblemont, Catherine (Hôpital Saint-Louis) ; Wahlin, Björn E. (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Sakellari, Ioanna (George Papanicolaou General Hospital) ; Russell, Nigel (Nottingham University Hospital) ; Janikova, Andrea (University Hospital Brno (República Txeca)) ; Dabrowska-Iwanicka, Anna (Maria Sklodowska-Curie Institute-Oncology Center) ; Touzeau, Cyrille (CHU Nantes) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Jantunen, Esa (University of Eastern Finland and Kuopio University Hospital) ; van der Werf, Steffie (EBMT Data Office) ; Bosman, Paul (EBMT Data Office) ; Boumendil, Ariane (EBMT Statistical Unit) ; Liu, Qianying (Sanofi Genzyme) ; Celanovic, Marina (Sanofi Genzyme) ; Montoto, Silvia (St Bartholomew's Hospital) ; Dreger, Peter (University of Heidelberg) ; Universitat Autònoma de Barcelona
Plerixafor + granulocyte-colony stimulating factor (G-CSF) is administered to patients with lymphoma who are poor mobilizers of hematopoietic stem cells (HSCs) in Europe. This international, multicenter, non-interventional registry study (NCT01362972) evaluated long-term follow-up of patients with lymphoma who received plerixafor for HSC mobilization versus other mobilization methods. [...]
2020 - 10.1038/s41409-019-0693-z
Bone marrow transplantation, Vol. 55 Núm. 3 (january 2020) , p. 613-622  
3.
15 p, 1.3 MB Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population : diagnostic and prognostic implications / Baptista, Maria Joao (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Tapia, Gustavo (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Muñoz-Marmol, Ana Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Muncunill Farreny, Josep (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; García, Olga (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Montoto, Silvia (Centre for Haemato-Oncology. Barts Cancer Institute. Queen Mary University of London) ; Gribben, John G. (Centre for Haemato-Oncology. Barts Cancer Institute. Queen Mary University of London) ; Calaminici, Maria (Centre for Haemato-Oncology. Barts Cancer Institute. Queen Mary University of London) ; Martinez, Antonio (Hospital Clínic i Provincial de Barcelona) ; Veloza, Luis (Hospital Clínic i Provincial de Barcelona) ; Martínez-Trillos, Alejandra (Hospital Clínic i Provincial de Barcelona) ; Aldámiz-Echevarría, T (Hospital General Universitario Gregorio Marañón) ; Menarguez, Javier (Hospital General Universitario Gregorio Marañón) ; Terol, Maria José (Hospital Clínic Universitari (València)) ; Ferrandez, Antonio (Hospital Clínic Universitari (València)) ; Alcoceba, Miguel (Hospital Universitario de Salamanca) ; Briones Meijide, Javier (Institut d'Investigació Biomèdica Sant Pau) ; Gonzalez-Barca, Eva (Hospital Duran i Reynals (Hospitalet del Llobregat)) ; Climent, Fina (Institut d'Investigació Biomèdica de Bellvitge) ; Muntañola, Ana (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Moraleda, José Maria (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ; Provencio, Mariano (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Abrisqueta, Pau (Hospital Universitari Vall d'Hebron) ; Abella Monreal, Eugenia (Hospital del Mar (Barcelona, Catalunya)) ; Colomo, Luis (Hospital del Mar (Barcelona, Catalunya)) ; García-Ballesteros, Carlos (Hospital Arnau de Vilanova (València)) ; Garcia-Caro, Montserrat (Hospital de Mataró. Consorci Sanitari del Maresme) ; Sancho, Juan-Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ribera, José Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mate Sanz, Jose Luís (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Navarro, José-Tomás (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
The frequency of aggressive subtypes of B-cell non-Hodgkin lymphoma (B-NHL), such as high-grade B-cell lymphomas (HGBL) with MYC and BCL2 and/or BCL6 rearrangement (HGBL-DH/TH) or Burkitt-like lymphoma (BL) with 11q aberration, is not well known in the HIV setting. [...]
2022 - 10.1111/his.14798
Histopathology, 2022  

Vegeu també: autors amb noms similars
1 Montoto, S.
1 Montoto, Santiago,
1 Montoto, Sylvia
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.